CHINA: Jade Pharmaceutical—a subsidiary of AMDL, Inc., a Tustin, CA-based pharmaceuticals company—said it plans to launch capsule and lotion forms of Goodnak, its injectable anti-aging skin care product sold in China. The new formulations, which will be available in the third quarter, will be priced at $40 per unit. JPI plans to sell both products through existing distribution channels within the Henan, Sichuan, Guizhou, Shanxi, Xinjiang, Gansu, Hunnan, Zhejiang, Fujian, Liaoning and Heilongjiang provinces of China. In addition to China, AMDL believes both products will be good candidates for export to the North American and European markets.
According to Gary Dreher, chief executive officer of AMDL, “With the popularity of the Goodnak brand in China, combined with JPI’s ability to sell through pre-approved distribution channels, we anticipate sales to exceed well beyond our initial annual sales forecast for Goodnak of $24 million.”
More info: www.amdl.com